Company / EPS (Diluted)
Rani Therapeutics Holdings, Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.05
FY2025
5-year range
-$1.33 / -$0.43
FY2021-FY2025
Trend
+21.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.43 to $-1.05 over the past 3 years.
Based on SEC 10-K filings.
-1.05 in FY2025.
Declined from $-0.43 to $-1.05 over the past 3 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 21.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.05 | +21.1% |
| FY2024 | -$1.33 | -209.3% |
| FY2022 | -$0.43 | +0.0% |
| FY2021 | -$0.43 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026